Your browser doesn't support javascript.
A public-private partnership model for COVID-19 diagnostics.
Krijger, Peter H L; Hoek, Tim A; Boersma, Sanne; Donders, Lieke I P M; Broeders, Maaike M C; Pieterse, Mark; Toonen, Pim W; Logister, Ive; Verhagen, Bram M P; Verstegen, Marjon J A M; van Ravesteyn, Thomas W; Roymans, Rene J T M; Mattiroli, Francesca; Vandesompele, Jo; Nijhuis, Monique; Meijer, Stefan; van Weert, Anton; Dekker, Edwin; Dom, Fred J; Ruijtenbeek, Rob; van der Velden, Lieven B J; van de Bovenkamp, Jeroen H B; Bosch, Martijn; de Laat, Wouter; Tanenbaum, Marvin E.
  • Krijger PHL; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.
  • Hoek TA; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.
  • Boersma S; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.
  • Donders LIPM; Laboratory of Medical Microbiology, Stichting PAMM, Veldhoven, the Netherlands.
  • Broeders MMC; Laboratory of Medical Microbiology, Stichting PAMM, Veldhoven, the Netherlands.
  • Pieterse M; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.
  • Toonen PW; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.
  • Logister I; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.
  • Verhagen BMP; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.
  • Verstegen MJAM; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.
  • van Ravesteyn TW; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.
  • Roymans RJTM; Laboratory of Medical Microbiology, Stichting PAMM, Veldhoven, the Netherlands.
  • Mattiroli F; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.
  • Vandesompele J; InActiv Blue, Beernem, Belgium.
  • Nijhuis M; Biogazelle, Zwijnaarde, Belgium.
  • Meijer S; Department of Medical Microbiology, University Medical Center, Utrecht, the Netherlands.
  • van Weert A; Tecan labwerx, Tecan Trading AG, Männedorf, Switzerland.
  • Dekker E; National Screening Laboratory Sanquin, Sanquin Diagnostics, Amsterdam, the Netherlands.
  • Dom FJ; Bodegro B.V, Breda, the Netherlands.
  • Ruijtenbeek R; HiFiBio Therapeutics, Saint-Jacques, France.
  • van der Velden LBJ; Department of Laboratory Automation, Genmab B.V., Utrecht, the Netherlands.
  • van de Bovenkamp JHB; Laboratory of Medical Microbiology, Stichting PAMM, Veldhoven, the Netherlands. l.van.der.velden@pamm.nl.
  • Bosch M; Laboratory of Medical Microbiology, Stichting PAMM, Veldhoven, the Netherlands.
  • de Laat W; Department of Laboratory Automation, Genmab B.V., Utrecht, the Netherlands. mbh@genmab.com.
  • Tanenbaum ME; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands. w.laat@hubrecht.eu.
Nat Biotechnol ; 39(10): 1182-1184, 2021 10.
Artículo en Inglés | MEDLINE | ID: covidwho-1442791

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Atención a la Salud / Asociación entre el Sector Público-Privado / SARS-CoV-2 / COVID-19 Tipo de estudio: Estudio observacional / Estudio pronóstico Límite: Humanos Idioma: Inglés Revista: Nat Biotechnol Asunto de la revista: Biotecnologia Año: 2021 Tipo del documento: Artículo País de afiliación: S41587-021-01080-6

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Atención a la Salud / Asociación entre el Sector Público-Privado / SARS-CoV-2 / COVID-19 Tipo de estudio: Estudio observacional / Estudio pronóstico Límite: Humanos Idioma: Inglés Revista: Nat Biotechnol Asunto de la revista: Biotecnologia Año: 2021 Tipo del documento: Artículo País de afiliación: S41587-021-01080-6